27.03.2013 Views

Cinchona officinalis L (Peruvian bark), Rubiaceae ... - AaronsWorld

Cinchona officinalis L (Peruvian bark), Rubiaceae ... - AaronsWorld

Cinchona officinalis L (Peruvian bark), Rubiaceae ... - AaronsWorld

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

3.5 Ecological Status<br />

Moderately threatened by logging and harvesting for medicine, though medicinal harvesting has been<br />

greatly reduced by availability of cultivated stock.<br />

3.6 Cultivation<br />

Extremely complex and difficult, but now widely established in India, Indonesia and Zaire.<br />

3.7 Wildcrafting<br />

Unclear to what extent this is still practiced due to large-scale cultivated supplies.<br />

4 Advanced Clinical Information<br />

4.1 Additional Actions<br />

¯ Schizontocidal against Plasmodium spp, useful for treatment and suppression.<br />

¯ Anti-ameba (Borris and Schaeffer 1992)<br />

¯ Inhibition of muldrug resistance pump<br />

¯ Negative inotropic<br />

¯ Insulin secratagogue<br />

<strong>Cinchona</strong> alkaloids act primarily as blood schizonticides. Schizonts are the form of malaria that<br />

exist in red blood cells before giving rise to merozoites, which reinvade red blood cells and split into<br />

sexual forms that penetrate into mosquitoes. Quinine also kills these sexual forms (gametocytes)<br />

for the P. malariae and P. vivax forms. Though quinine and related alkaloids may have some effect<br />

against sporozoites that come out of mosquitoes and actually start a malaria infection, they are not<br />

well-established for preventing malaria, though historical reports suggest they might be protective.<br />

Quinine and related alkaloids do not appear to affect the hynozoites that persist in the liver or any<br />

exoerythrocytic forms of malaria, and thus cannot completely eradicate (cause a so-called radical cure)<br />

malaria on their own in patient infected with P. ovale or P. vivax, which have exoerythrocytic forms.<br />

4.2 Additional Indications<br />

¯ Leg cramps<br />

¯ Babesiosis<br />

¯ Amebiasis<br />

¯ Cancer chemotherapy resistance reversal<br />

Mixed results in controlled clinical trials led to FDA revoking the over-the-counter status for quinine<br />

used to treat leg cramps in 1995 (Man-Son-Hing and Wells 1995).<br />

In a phase I trial, intravenous cinchonine appeared to reverse multidrug resistance in patients with<br />

lymphoproliferative syndromes treated with chemotherapy, but there was concern about potential for<br />

8

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!